Seagen Inc.
SGENDelisted Dec 14, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Seagen Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 614 | 9 | 5 | −600 |
| Shares | 170.8M | 251.2K | 1.71K | −170.5M (−100.0%) |
| Value | $36.3B | $53.3M | $386.8K | −$36.2B (−100.0%) |
9 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Seagen Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Valued Wealth Advisors LLC | 23 | $4.88K | 0.00% |
Sold out (601)
Institutions that held Seagen Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
Showing the largest 100 of 601 by value.
Not filed for Q4 2023 yet (9)
Institutions that held Seagen Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Berry Street Capital Management LLP | 206,250 | $43.8M |
| Decheng Capital Management III (Cayman), LLC | 23,014 | $4.88M |
| Terrapin Asset Management, LLC | 14,000 | $2.97M |
| Pathstone Family Office, LLC | 3,780 | $833.8K |
| First Republic Investment Management, Inc. | 2,282 | $484.1K |
| Advisor Partners II, LLC | 1,596 | $338.6K |
| KB Financial Partners, LLC | 219 | $46.0K |
| Steward Financial Group LLC | 27 | $5.00K |
| Sutton Wealth Advisors Inc. | 8 | $1.70K |